Guanosine regulates adenosine levels in the kidney

Physiological Reports

Volumn 2, Issue 5, 2014, Pages

  Jackson, Edwin K ^a   Cheng, Dongmei ^a   Mi, Zaichuan ^a   Gillespie, Delbert G ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

8 Aminoguanine; Adenosine; Guanosine; Inosine; Kidney; Purine nucleoside phosphorylase

Indexed keywords

ADENOSINE; GUANOSINE; INOSINE; IODOACETIC ACID; OXYGEN; POISON; POLYRIBONUCLEOTIDE NUCLEOTIDYLTRANSFERASE; PURINE NUCLEOSIDE PHOSPHORYLASE;

ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; KIDNEY; KIDNEY PARENCHYMA; MALE; METABOLISM; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PERFUSION; RENAL CLEARANCE; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 85002965253     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12028     Document Type: Article

References (52)

1. Bauerle, J. D., A. Grenz, J.-H. Kim, H. T. Lee, and H. K. Eltzschig. 2011. Adenosine generation and signaling during acute kidney injury. J. Am. Soc. Nephrol. 22: 14-20.
2. Bours, M. J. L., E. L. R. Swennen, F. Di Virgilio, B. N. Cronstein, and P. C. Dagnelie. 2006. Adenosine 50-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 112:358-404.
3. Chern, J. W., H. Y. Lee, C. S. Chen, D. S. Shewach, P. E. Daddona, and L. B. Townsend. 1993. Nucleosides. 5. Synthesis of guanine and formycin B derivatives as potential inhibitors of purine nucleoside phosphorylase. J. Med. Chem. 36:1024-1031.
4. Day, Y.-J., L. Huang, H. Ye, J. Linden, and M. D. Okusa. 2005. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am. J. Physiol. Renal Physiol. 288:F722-F731.
5. Denton, K. M., A. Shweta, and W. P. Anderson. 2002. Preglomerular and postglomerular resistance responses to different levels of sympathetic activation by hypoxia. J. Am. Soc. Nephrol. 13:27-34.
6. Desquiret, V., D. Loiseau, C. Jacques, O. Douay, Y. Malthiery, P. Ritz, et al. 2006. Dinitrophenol-induced mitochondrial uncoupling in vivo triggers respiratory adaptation in HepG2 cells. Biochim. Biophys. Acta 1757:21-30.
7. Fitzpatrick, J. M., D. M. Wallace, H. N. Whitfield, L. E. Watkinson, A. R. Fernando, and J. E. Wickham. 1981. Inosine in ischaemic renal surgery: long-term follow-up. Br. J. Urol. 53:524-527.
8. Fredholm, B. B. 2010. Adenosine receptors as drug targets. Exp. Cell Res. 316:1284-1288.
9. Fredholm, B. B., S. Johansson, and Y.-Q. Wang. 2011. Adenosine and the regulation of metabolism and body temperature. Adv. Pharmacol. 61:77-94.
10. Giblett, E. R. 1985. ADA and PNP deficiencies: how it all began. Ann. N. Y. Acad. Sci. 451:1-8.
11. Grenz, A., H. Osswald, T. Eckle, D. Yang, H. Zhang, Z. V. Tran, et al. 2008. The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med. 5:e137.
12. Grenz, A., D. Homann, and H. K. Eltzschig. 2011. Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia. Antioxid. Redox Signal. 15:2221-2234.
13. Grenz, A., J. D. Bauerle, J. H. Dalton, D. Ridyard, A. Badulak, E. Tak, et al. 2012. Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. J. Clin. Invest. 122:693-710.
14. Hespel, P., and E. A. Richter. 1998. Role of adenosine in regulation of carbohydrate metabolism in contracting muscle. Adv. Exp. Med. Biol. 441:97-106.
15. Jackson, E. K., and D. G. Gillespie. 2013. Regulation of cell proliferation by the guanosine-adenosine mechanism: role of adenosine receptors. Physiol. Rep. 1:e00024.
16. Jackson, E. K., D. Cheng, T. C. Jackson, J. D. Verrier, and D. G. Gillespie. 2013. Extracellular guanosine regulates extracellular adenosine levels. Am. J. Physiol. Cell Physiol. 304:C406-C421.
17. Jacobson, K. A. 2009. Introduction to adenosine receptors as therapeutic targets. Handb. Exp. Pharmacol. 193:1-24.
18. Joel, C. D., W. B. Neaves, and J. M. Rabb. 1967. Mitochondria of brown fat: oxidative phosphorylation sensitive to 2,4,-dinitrophenol. Biochem. Biophys. Res. Commun. 29:490-495.
19. Kaminsky, Y. G., and E. A. Kosenko. 1987. Different effects of 2,4-dinitrophenol on rat liver mitochondrial oxidation of various substrates: succinate and glutamate vs 3-hydroxybutyrate and glycerol 3-phosphate. Int. J. Biochem. 19:97-99.
20. Kelly, K. J., Z. Plotkin, and P. C. Dagher. 2001. Guanosine supplementation reduces apoptosis and protects renal function in the setting of ischemic injury. J. Clin. Invest. 108:1291-1298.
21. Kim, M., S. W. C. Chen, S. W. Park, M. Kim, V. D. D’Agati, J. Yang, et al. 2009. Kidney-specific reconstitution of the A1 adenosine receptor in A1 adenosine receptor knockout mice reduces renal ischemia-reperfusion injury. Kidney Int. 75:809-823.
22. Konings, A. W. 1971. The influence of iodoacetate on the mechanism of nuclear glucose oxidation. Experientia 27:253-254.
23. Kumar, V., and A. Sharma. 2009. Adenosine: an endogenous modulator of innate immune system with therapeutic potential. Eur. J. Pharmacol. 616:7-15.
24. Lee, H. T., and C. W. Emala. 2000. Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A1 and A3 receptors. Am. J. Physiol. Renal Physiol. 278: F380-F387.
25. Lee, H. T., and C. W. Emala. 2002. Adenosine attenuates oxidant injury in human proximal tubular cells via A1 and A2a adenosine receptors. Am. J. Physiol. Renal Physiol. 282: F844-F852.
26. Lee, H. T., M. Kim, M. Jan, R. B. Penn, and C. W. Emala. 2007. Renal tubule necrosis and apoptosis modulation by A1 adenosine receptor expression. Kidney Int. 71:1249-1261.
27. Maggio, A. J. Jr, S. Das, R. B. Smith, and J. J. Kaufman. 1980. Renal preservation with inosine. Urology 16:343-345.
28. Marberger, M., R. Gunther, P. Alken, W. Rumpf, and M. Ranc. 1980. Inosine: alternative or adjunct to regional hypothermia in the prevention of post-ischemic renal failure? Eur. Urol. 6:95-102.
29. Marshall, J. M. 2002. Roles of adenosine in skeletal muscle during systemic hypoxia. Clin. Exp. Pharmacol. Physiol. 29:843-849.
30. Mathur, V. K., and E. W. Ramsey. 1983. Comparison of methods for preservation of renal function during ischemic renal surgery. J. Urol. 129:163-165.
31. McKee, R. W., W. Wong, and M. Landman. 1965. Effects of iodoacetate on glycolysis and respiration in Ehrlich-Lettre ascites carcinoma cells. Biochim. Biophys. Acta 105:410-423.
32. McKee, R. W., M. E. Parks, and A. Dickey. 1968. Influence of iodoacetate on glycolytic intermediates and on respiration in Ehrlich-Lettre ascites carcinoma cells. Arch. Biochem. Biophys. 124:450-455.
33. Mohsenin, A., and M. R. Blackburn. 2006. Adenosine signaling in asthma and chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med. 12:54-59.
34. Mustafa, S. J., R. R. Morrison, B. Teng, and A. Pelleg. 2009. Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology. Handb. Exp. Pharmacol. 193:161-188.
35. Okusa, M. D. 2002. A2A adenosine receptor: a novel therapeutic target in renal disease. Am. J. Physiol. Renal Physiol. 282:F10-F18.
36. Okusa, M. D., J. Linden, T. MacDonald, and L. Huang. 1999. Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney. Am. J. Physiol. Renal Physiol. 277:F404.
37. Okusa, M. D., J. Linden, L. Huang, J. M. Rieger, T. L. MacDonald, and L. P. Huynh. 2000. A2A adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. Am. J. Physiol. Renal Physiol. 279:F809-F818.
38. Okusa, M. D., J. Linden, L. Huang, D. L. Rosin, D. F. Smith, and G. Sullivan. 2001. Enhanced protection from renal ischemia-reperfusion injury with A2A-adenosine receptor activation and PDE 4 inhibition. Kidney Int. 59:2114-2125.
39. Oppermann, M., P. B. Hansen, H. Castrop, and J. Schnermann. 2007. Vasodilatation of afferent arterioles and paradoxical increase of renal vascular resistance by furosemide in mice. Am. J. Physiol. Renal Physiol. 293: F279-F287.
40. Pelleg, A., G. Katchanov, and J. Xu. 1997. Autonomic neural control of cardiac function: modulation by adenosine and adenosine 50-triphosphate. Am. J. Cardiol. 79:11-14.
41. Peng, Z., P. Fernandez, T. Wilder, H. Yee, L. Chiriboga, E. S. L. Chan, et al. 2008. Ecto-50-nucleotidase (CD73)-mediated extracellular adenosine production plays a critical role in hepatic fibrosis. Nucleosides, Nucleotides Nucleic Acids 27:821-824.
42. Rothwell, D., J. Bartley, and M. James. 1981. Preservation of the ischaemic canine kidney with inosine. Urol. Res. 9:75-78.
43. Sebastiao, A. M., and J. A. Ribeiro. 2009. Adenosine receptors and the central nervous system. Handb. Exp. Pharmacol. 193:471-534.
44. Seegmiller, J. E. 1985. Overview of possible relation of defects in purine metabolism to immune deficiency. Ann. N. Y. Acad. Sci. 451:9-19.
45. Thauerer, B., S. zur Nedden, and G. Baier-Bitterlich. 2012. Purine nucleosides: endogenous neuroprotectants in hypoxic brain. J. Neurochem. 121:329-342.
46. Traversa, U., G. Bombi, E. Camaioni, A. Macchiarulo, G. Costantino, C. Palmieri, et al. 2003. Rat brain guanosine binding site. Biological studies and pseudo-receptor construction. Bioorg. Med. Chem. 11:5417-5425.
47. Trincavelli, M. L., S. Daniele, and C. Martini. 2010. Adenosine receptors: what we know and what we are learning. Curr. Top. Med. Chem. 10:860-877.
48. Vallon, V., B. Muhlbauer, and H. Osswald. 2006. Adenosine and kidney function. Physiol. Rev. 86:901-940.
49. Vass, G., and I. Horvath. 2008. Adenosine and adenosine receptors in the pathomechanism and treatment of respiratory diseases. Curr. Med. Chem. 15:917-922.
50. Westfall, D. P., K. Shinozuka, K. M. Forsyth, and R. A. Bjur. 1990. Presynaptic purine receptors. Ann. N. Y. Acad. Sci. 604:130-135.
51. Yu, W., L. C. Zacharia, E. K. Jackson, and G. Apodaca. 2006. Adenosine receptor expression and function in bladder uroepithelium. Am. J. Physiol. Cell Physiol. 291: C254-C265.
52. Yu, W., S. C. Robson, and W. G. Hill. 2011. Expression and distribution of ectonucleotidases in mouse urinary bladder. PLoS One 6:e18704.